- Aug 2, 2022

The role of osteoanabolic agents in the management of patients with osteoporosis

Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators Khan AA, AbuAlrob H, Al-Alwani H, et al. Osteoporos Int. 2023 Ju

To Break or Not to Break (Again): Is That the Question?

Kherani RB, Singh S. CRAJ. 2022;32(3):1 2 * Posted with permission from publisher

Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review

Kendler DL, Cosman F, Stad RK, Ferrari S . Adv Ther. 2022 Jan;39(1):58-74. doi: 10.1007/s12325-021-01936-y. Epub 2021 Nov 11. PMID: 34762286 Free PMC article. Review.

The role of osteoanabolic agents in the management of patients with osteoporosis

Related Posts